Analysis of IVIM Perfusion Fraction Improves Detection of Pancreatic Ductal Adenocarcinoma

被引:0
|
作者
Nadolska, Katarzyna [1 ]
Bialecka, Agnieszka [1 ]
Zawada, Elzbieta [1 ]
Kazimierczak, Wojciech [1 ]
Serafin, Zbigniew [1 ]
机构
[1] Nicolaus Copernicus Univ Torun, Coll Med, Jagiellonska 13-15, PL-85067 Bydgoszcz, Poland
关键词
pancreatic ductal adenocarcinoma; intravoxel incoherent motion; diffusion-weighted imaging; perfusion-dependent diffusion coefficient; diagnostic accuracy; INTRAVOXEL INCOHERENT MOTION; DIFFUSION; DIFFERENTIATION; CANCER; MRI; EPIDEMIOLOGY; TUMOR; MODEL; HEAD;
D O I
10.3390/diagnostics14060571
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to evaluate whether intravoxel incoherent motion (IVIM) parameters can enhance the diagnostic performance of MRI in differentiating normal pancreatic parenchyma from solid pancreatic adenocarcinomas. This study included 113 participants: 66 patients diagnosed with pancreatic adenocarcinoma and 47 healthy volunteers. An MRI was conducted at 1.5 T MR unit, using nine b-values. Postprocessing involved analyzing both conventional monoexponential apparent diffusion coefficient (ADC) and IVIM parameters (diffusion coefficient D-pure molecular diffusion coefficient, perfusion-dependent diffusion coefficient D*-pseudodiffusion coeffitient, and perfusion fraction coefficient (f)) across four different b-value selections. Significantly higher parameters were found in the control group when using high b-values for the pure diffusion analysis and all b-values for the monoexponential analysis. Conversely, in the study group, the parameters were affected by low b-values. Most parameters could differentiate between normal and cancerous tissue, with D* showing the highest diagnostic performance (AUC 98-100%). A marked decrease in perfusion in the patients with pancreatic cancer, indicated by the significant differences in the D* medians between groups, was found. In conclusion, standard ADC maps alone may not suffice for a definitive pancreatic cancer diagnosis, and incorporating IVIM into MRI protocols is recommended, as the reduced tissue perfusion detected by the IVIM parameters is a promising marker for pancreatic adenocarcinoma.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Biomarker detection in pancreatic ductal adenocarcinoma
    Klett, H.
    Klose, M.
    Kowar, S.
    Bronsert, P.
    Kuesters, S.
    Werner, M.
    Christoph, P.
    Busch, H.
    Boerries, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S177 - S178
  • [2] Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma
    K K Y Cham
    J H E Baker
    K S Takhar
    J A Flexman
    M Q Wong
    D A Owen
    A Yung
    P Kozlowski
    S A Reinsberg
    E M Chu
    C-W A Chang
    A K Buczkowski
    S W Chung
    C H Scudamore
    A I Minchinton
    D T T Yapp
    S S W Ng
    British Journal of Cancer, 2010, 103 : 52 - 60
  • [3] Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma
    Cham, K. K. Y.
    Baker, J. H. E.
    Takhar, K. S.
    Flexman, J. A.
    Wong, M. Q.
    Owen, D. A.
    Yung, A.
    Kozlowski, P.
    Reinsberg, S. A.
    Chu, E. M.
    Chang, C-W A.
    Buczkowski, A. K.
    Chung, S. W.
    Scudamore, C. H.
    Minchinton, A. I.
    Yapp, D. T. T.
    Ng, S. S. W.
    BRITISH JOURNAL OF CANCER, 2010, 103 (01) : 52 - 60
  • [4] Pancreatic ductal adenocarcinoma (PDAC) early detection
    Hinestrosa, Juan P.
    Dhani, Harmeet
    Schroeder, Gregor
    Lewis, Jean M.
    Balcer, Heath I.
    Kurzrock, Razelle
    Keith, Dove
    Sears, Rosalie
    Billings, Paul
    CANCER RESEARCH, 2023, 83 (07)
  • [5] Proteomic analysis of pancreatic ductal adenocarcinoma
    Meleady, Paula
    Rahman, Rozana Abdul
    Henry, Michael
    Moriarty, Michael
    Clynes, Martin
    EXPERT REVIEW OF PROTEOMICS, 2020, 17 (06) : 453 - 467
  • [6] Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma
    Esther Llop
    Pedro E Guerrero
    Adrià Duran
    Sílvia Barrabés
    Anna Massaguer
    María José Ferri
    Maite Albiol-Quer
    Rafael de Llorens
    Rosa Peracaula
    World Journal of Gastroenterology, 2018, (24) : 2537 - 2554
  • [7] Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma
    Llop, Esther
    Guerrero, Pedro E.
    Duran, Adria
    Barrabes, Silvia
    Massaguer, Anna
    Jose Ferri, Maria
    Albiol-Quer, Maite
    de Llorens, Rafael
    Peracaula, Rosa
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (24) : 2537 - 2554
  • [8] Automated Quantitative Analysis of CT Perfusion to Classify Vascular Phenotypes of Pancreatic Ductal Adenocarcinoma
    Perik, Tom
    Alves, Natalia
    Hermans, John J.
    Huisman, Henkjan
    CANCERS, 2024, 16 (03)
  • [9] Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis
    Tamburrino, Domenico
    Crippa, Stefano
    Partelli, Stefano
    Archibugi, Livia
    Arcidiacono, Paolo Giorgio
    Falconi, Massimo
    Capurso, Gabriele
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (04) : 392 - 399
  • [10] Dynamic perfusion CT - A promising tool to diagnose pancreatic ductal adenocarcinoma
    Zaboriene, Inga
    Barauskas, Giedrius
    Gulbinas, Antanas
    Ignatavicius, Povilas
    Lukosevicius, Saulius
    Zviniene, Kristina
    OPEN MEDICINE, 2021, 16 (01): : 284 - 292